Cytarabine and Nasal polyps - a phase IV clinical study of FDA data

Summary:

Nasal polyps is reported only by a few people who take Cytarabine.

The phase IV clinical study analyzes which people take Cytarabine and have Nasal polyps. It is created by eHealthMe based on reports of 47,201 people who have side effects while taking Cytarabine from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

47,201 people reported to have side effects when taking Cytarabine.
Among them, 2 people (0.0%) have Nasal polyps.


What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 47,240 Cytarabine users for its effectiveness, alternative drugs and more.

What is Nasal polyps?

Nasal polyps (masses that develop in the lining of the nose) is found to be associated with 655 drugs and 322 conditions by eHealthMe.

Number of Cytarabine and Nasal polyps reports submitted per year:

Could Cytarabine cause Nasal polyps?

Time on Cytarabine when people have Nasal polyps *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Nasal polyps when taking Cytarabine *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Nasal polyps when taking Cytarabine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 50 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 50 %

Common drugs people take besides Cytarabine *:

  1. Vfend: 1 person, 50.00%
  2. Senna: 1 person, 50.00%
  3. Rhinocort: 1 person, 50.00%
  4. Nystatin: 1 person, 50.00%
  5. Nasacort: 1 person, 50.00%
  6. Lisinopril: 1 person, 50.00%
  7. Lipitor: 1 person, 50.00%
  8. Lansoprazole: 1 person, 50.00%
  9. Fungizone: 1 person, 50.00%
  10. Fluconazole: 1 person, 50.00%

Common side effects people have besides Nasal polyps *:

  1. Upper-Airway Cough Syndrome: 1 person, 50.00%
  2. Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 1 person, 50.00%
  3. Back Pain: 1 person, 50.00%
  4. Breathing - Slowed Or Stopped: 1 person, 50.00%
  5. Chest Pain: 1 person, 50.00%
  6. Consciousness - Decreased: 1 person, 50.00%
  7. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 50.00%
  8. Depression: 1 person, 50.00%
  9. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 50.00%
  10. High Blood Cholesterol: 1 person, 50.00%

Common conditions people have *:

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 50.00%
  2. Acne (skin problems that cause pimples): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Nasal polyps?

Check whether Nasal polyps is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Cytarabine:

Nasal polyps treatments and more:

COVID vaccines that are related to Nasal polyps:

How severe was Nasal polyps and when was it recovered:

Expand to all the drugs that have ingredients of cytarabine:

Common drugs associated with Nasal polyps:

All the drugs that are associated with Nasal polyps:

Common conditions associated with Nasal polyps:

All the conditions that are associated with Nasal polyps:

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: